Monday 26 June 2017

Global Patient Handling Equipment Industry 2017 Market Report; Launched via MarketResearchReports.com

Global Patient Handling Equipment Industry Market Research 2017

In this report, we analyze the Patient Handling Equipment industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also make a prediction of its production and consumption in coming 2017-2022.

At the same time, we classify different Patient Handling Equipment based on their definitions. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What is more, the Patient Handling Equipment industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.


The report can answer the following questions:
1. What is the global (North America, South America, Europe, Africa, Middle East, Asia, China, Japan) production, production value, consumption, consumption value, import and export of Patient Handling Equipment?
2. Who are the global key manufacturers of Patient Handling Equipment industry? How are their operating situation (capacity, production, price, cost, gross and revenue)?
3. What are the types and applications of Patient Handling Equipment? What is the market share of each type and application?
4. What are the upstream raw materials and manufacturing equipment of Patient Handling Equipment? What is the manufacturing process of Patient Handling Equipment?
5. Economic impact on Patient Handling Equipment industry and development trend of Patient Handling Equipment industry.
6. What will the Patient Handling Equipment market size and the growth rate be in 2022?
7. What are the key factors driving the global Patient Handling Equipment industry?
8. What are the key market trends impacting the growth of the Patient Handling Equipment market?
9. What are the Patient Handling Equipment market challenges to market growth?
10. What are the Patient Handling Equipment market opportunities and threats faced by the vendors in the global Patient Handling Equipment market?

Objective of Studies:
1. To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Patient Handling Equipment market.
2. To provide insights about factors affecting the market growth. To analyze the Patient Handling Equipment market based on various factors- price analysis, supply chain analysis, porte five force analysis etc.
3. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World.
4. To provide country level analysis of the market with respect to the current market size and future prospective.
5. To provide country level analysis of the market for segment by application, product type and sub-segments.
6. To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
7. To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Patient Handling Equipment market.

Spanning over 160 pages Global Patient Handling Equipment Industry Market Research 2017” report covers Industry Overview of Patient Handling Equipment, Industry Chain Analysis of Patient Handling Equipment, Manufacturing Technology of Patient Handling Equipment, Major Manufacturers Analysis of Patient Handling Equipment, Global Production, Revenue and Price Analysis of Patient Handling Equipment by Regions, Manufacturers, Types and Applications, Global and Major Regions Capacity, Production, Revenue and Growth Rate of Patient Handling Equipment 2012-2017, Consumption Volume, Consumption Value, Import, Export and Sale Price Analysis of Patient Handling Equipment by Regions, Gross and Gross Margin Analysis of Patient Handling Equipment, Marketing Trader or Distributor Analysis of Patient Handling Equipment, Global and Chinese Economic Impact on Patient Handling Equipment Industry, Development Trend Analysis of Patient Handling Equipment, Contact information of Patient Handling Equipment, New Project Investment Feasibility Analysis of Patient Handling Equipment, Conclusion of the Global Patient Handling Equipment Industry 2017 Market Research Report.

Please visit this link for more details: http://mrr.cm/Umz

For related reports please visit: Patient Handling Equipment Market Research Reports

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

Global Head Lice Infestation Drug Market Research 2011 - 2022 Market Report; Launched via MarketResearchReports.com

Global Head Lice Infestation Drug Market Research 2011 - 2022

Head lice are tiny wingless insects that do not fly or jump, their primary means of movement is crawling. The main way lice are spread is head to head contact. Lice are human parasites that feed on the blood of the infested person. Head Lice Infestation Drug is to kill lice or kill eggs.

The Global Head Lice Infestation Drug market is estimated to reach 563.1 Million USD in 2017. On the basis of region, North America is the largest market segment of Head Lice Infestation Drug, followed by Europe and Asia. In the report, HeyReport says Children dominates the largest Application share in 2017. The objective of report is to define, segment, and project the market on the basis of type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
By Type
  • Lotion
  • Creams
  • Shampoo

Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
  • North America
  • Europe
  • Asia
  • South America
  • Africa

Based on Application, the report describes major Application share of regional market. Application mentioned as follows:
  • Children
  • Adult

Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
  • Bayer
  • Omega Pharma
  • Thornton and Ross
  • Prestige Brands
  • Perrigo
  • Actavis
  • Reckitt Benckier
  • Tyratech
  • Shionogi
  • TecLabs
  • Arborpharma
  • Major Pharmaceuticals
  • Logic Products
  • Tianren
  • ParaPRO

Spanning over 78 pages Global Head Lice Infestation Drug Market Research 2011 - 2022” report covers Market Overview, Industry Chain, Environmental Analysis, Market Segmentation by Type, Market Segmentation by Application, Market Segmentation by Region, Market Competitive, Major Vendors, Conclusion.

Please visit this link for more details: http://mrr.cm/UmV

Related Reports;

Global Ambulatory Surgery Center (ASC) Market Research 2011- 2022 - Visit at - http://mrr.cm/Umj

Global Artificial Tears Market Research 2011- 2022 - Visit at - http://mrr.cm/Um9

Find all Pharma & Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

Global Epidermal Growth Factor Industry 2017 Market Report; Launched via MarketResearchReports.com

Global Epidermal Growth Factor (EGF) Industry Market Research 2017

In this report, we analyze the Epidermal Growth Factor (EGF) industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also make a prediction of its production and consumption in coming 2017-2022.

At the same time, we classify different Epidermal Growth Factor (EGF) based on their definitions. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What is more, the Epidermal Growth Factor (EGF) industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.


The report can answer the following questions:
1. What is the global (North America, South America, Europe, Africa, Middle East, Asia, China, Japan) production, production value, consumption, consumption value, import and export of Epidermal Growth Factor (EGF)?
2. Who are the global key manufacturers of Epidermal Growth Factor (EGF) industry? How are their operating situation (capacity, production, price, cost, gross and revenue)?
3. What are the types and applications of Epidermal Growth Factor (EGF)? What is the market share of each type and application?
4. What are the upstream raw materials and manufacturing equipment of Epidermal Growth Factor (EGF)? What is the manufacturing process of Epidermal Growth Factor (EGF)?
5. Economic impact on Epidermal Growth Factor (EGF) industry and development trend of Epidermal Growth Factor (EGF) industry.
6. What will the Epidermal Growth Factor (EGF) market size and the growth rate be in 2022?
7. What are the key factors driving the global Epidermal Growth Factor (EGF) industry?
8. What are the key market trends impacting the growth of the Epidermal Growth Factor (EGF) market?
9. What are the Epidermal Growth Factor (EGF) market challenges to market growth?
10. What are the Epidermal Growth Factor (EGF) market opportunities and threats faced by the vendors in the global Epidermal Growth Factor (EGF) market?

Objective of Studies:
1. To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Epidermal Growth Factor (EGF) market.
2. To provide insights about factors affecting the market growth. To analyze the Epidermal Growth Factor (EGF) market based on various factors- price analysis, supply chain analysis, porte five force analysis etc.
3. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World.
4. To provide country level analysis of the market with respect to the current market size and future prospective.
5. To provide country level analysis of the market for segment by application, product type and sub-segments.
6. To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
7. To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Epidermal Growth Factor (EGF) market.

Spanning over 157 pages Global Epidermal Growth Factor (EGF) Industry Market Research 2017” report covers Industry Overview of Epidermal Growth Factor (EGF), Industry Chain Analysis of Epidermal Growth Factor (EGF), Manufacturing Technology of Epidermal Growth Factor (EGF), Major Manufacturers Analysis of Epidermal Growth Factor (EGF), Global Production, Revenue and Price Analysis of Epidermal Growth Factor (EGF) by Regions, Manufacturers, Types and Applications, Global and Major Regions Capacity, Production, Revenue and Growth Rate of Epidermal Growth Factor (EGF) 2012-2017, Consumption Volume, Consumption Value, Import, Export and Sale Price Analysis of Epidermal Growth Factor (EGF) by Regions, Gross and Gross Margin Analysis of Epidermal Growth Factor (EGF), Marketing Trader or Distributor Analysis of Epidermal Growth Factor (EGF), Global and Chinese Economic Impact on Epidermal Growth Factor (EGF) Industry, Development Trend Analysis of Epidermal Growth Factor (EGF), Contact information of Epidermal Growth Factor (EGF), New Project Investment Feasibility Analysis of Epidermal Growth Factor (EGF), Conclusion of the Global Epidermal Growth Factor (EGF) Industry 2017 Market Research Report.

Please visit this link for more details: http://mrr.cm/UmR

For related reports please visit: Epidermal Growth Factor Market Research Reports

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

Global Patient Infotainment Terminals Industry 2017 Market Report; Launched via MarketResearchReports.com

Global Patient Infotainment Terminals Industry Market Research 2017

In this report, we analyze the Patient Infotainment Terminals industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also make a prediction of its production and consumption in coming 2017-2022.

At the same time, we classify different Patient Infotainment Terminals based on their definitions. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What is more, the Patient Infotainment Terminals industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.


The report can answer the following questions:
1. What is the global (North America, South America, Europe, Africa, Middle East, Asia, China, Japan) production, production value, consumption, consumption value, import and export of Patient Infotainment Terminals?
2. Who are the global key manufacturers of Patient Infotainment Terminals industry? How are their operating situation (capacity, production, price, cost, gross and revenue)?
3. What are the types and applications of Patient Infotainment Terminals? What is the market share of each type and application?
4. What are the upstream raw materials and manufacturing equipment of Patient Infotainment Terminals? What is the manufacturing process of Patient Infotainment Terminals?
5. Economic impact on Patient Infotainment Terminals industry and development trend of Patient Infotainment Terminals industry.
6. What will the Patient Infotainment Terminals market size and the growth rate be in 2022?
7. What are the key factors driving the global Patient Infotainment Terminals industry?
8. What are the key market trends impacting the growth of the Patient Infotainment Terminals market?
9. What are the Patient Infotainment Terminals market challenges to market growth?
10. What are the Patient Infotainment Terminals market opportunities and threats faced by the vendors in the global Patient Infotainment Terminals market?

Objective of Studies:
1. To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Patient Infotainment Terminals market.
2. To provide insights about factors affecting the market growth. To analyze the Patient Infotainment Terminals market based on various factors- price analysis, supply chain analysis, porte five force analysis etc.
3. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World.
4. To provide country level analysis of the market with respect to the current market size and future prospective.
5. To provide country level analysis of the market for segment by application, product type and sub-segments.
6. To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
7. To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Patient Infotainment Terminals market.

Spanning over 155 pages Global Patient Infotainment Terminals Industry Market Research 2017” report covers Industry Overview of Patient Infotainment Terminals, Industry Chain Analysis of Patient Infotainment Terminals, Manufacturing Technology of Patient Infotainment Terminals, Major Manufacturers Analysis of Patient Infotainment Terminals, Global Production, Revenue and Price Analysis of Patient Infotainment Terminals by Regions, Manufacturers, Types and Applications, Global and Major Regions Capacity, Production, Revenue and Growth Rate of Patient Infotainment Terminals 2012-2017, Consumption Volume, Consumption Value, Import, Export and Sale Price Analysis of Patient Infotainment Terminals by Regions, Gross and Gross Margin Analysis of Patient Infotainment Terminals, Marketing Trader or Distributor Analysis of Patient Infotainment Terminals, Global and Chinese Economic Impact on Patient Infotainment Terminals Industry, Development Trend Analysis of Patient Infotainment Terminals, Contact information of Patient Infotainment Terminals, New Project Investment Feasibility Analysis of Patient Infotainment Terminals, Conclusion of the Global Patient Infotainment Terminals Industry 2017 Market Research Report.

Please visit this link for more details: http://mrr.cm/Umr


Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

Friday 23 June 2017

Respiratory Syncytial Virus Antibodies, Vaccines & Antivirals 2017; New Report Launched

Respiratory Syncytial Virus (RSV) Antibodies, Vaccines & Antivirals 2017

This Competitive Intelligence Report about RSV Antibodies, Vaccines & Antivirals provides a competitor evaluation in the field of prophylactic vaccines and therapeutic antibodies, small molecules, protein and peptide therapeutics against infection caused by respiratory syncytial virus (RSV) as of March 2017.

Respiratory syncytial virus (RSV) is the most common cause of lower respiratory tract infections among young children in the United States and worldwide. Most infants are infected before the age of one, and virtually everyone gets an RSV infection by the age of two. A prophylactic vaccine is not available and specific treatment is limited to the monoclonal antibody Synagis (palivizumb), a candidate for biosimilar conversion in the near future.

RSV infection in the pediatric and adult populations account for more than 300,000 hospitalizations per year in the U.S. In the developing world, RSV is responsible for 30 million cases of acute respiratory tract infection and 200,000 deaths per year. As a result, there is a significant need for novel therapeutics to prevent RSV infection.

The report includes a compilation of currently active projects in development of vaccines, antibodies, small molecules, peptides and proteins targeting respiratory syncytial virus for prophylaxis and treatment of RSV infections. In addition, the report lists company-specific R&D pipelines of RSV Antibodies, Vaccines & Antivirals.

Competitor projects are listed in a tabular format providing information on:
  • Drug Codes,
  • Target / Mechanism of Action,
  • Class of Compound,
  • Company,
  • Product Category,
  • Indication,
  • R&D Stage and
  • additional comments with a hyperlink leading to the source of information.

RSV Antibodies:
  • Palivizumab Biosuperiors
  • Palivizumab Biosimilars

RSV Antivirals:
  • Small Molecule Therapeuticss
  • Other RSV Therapeutics

RSV Vaccines:
  • Live-Attenuated & Whole-Inactivated RSV Vaccines
  • Virus-Like Particle (VLP) RSV Vaccines
  • Subunit RSV Vaccines
  • DNA-/RNA-Based RSV Vaccines

Please visit this link for more details: http://mrr.cm/Umu

Related Reports;

Competitor Analysis - Kallikrein Inhibitors 2017 - Visit at - http://mrr.cm/UmL

Blockbuster Biologics 2016: Sales of Recombinant Therapeutic Antibodies & Proteins - Visit at - http://mrr.cm/Umb

Competitor Analysis: Complement C5 Inhibitors 2017 - Biosuperiors & Biosimilars - Visit at - http://mrr.cm/UmE

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

Global Autologous Cell Therapy Market to grow at a CAGR of 23.39% during the period 2017 - 2021; Finds New Report

Global Autologous Cell Therapy Market 2017 - 2021

Report forecast the global autologous cell therapy market to grow at a CAGR of 23.39% during the period 2017-2021.

Autologous cell therapy belongs to the field of regenerative medicine and is based on biologic cell-based therapies to cure various diseases, including those of oncology, neurology, and dermatology, to name a few. Autologous cell therapy is one of the fastest growing segments of regenerative medicine and hence, is attracting significant research funds from various quarters.

The report covers the present scenario and the growth prospects of the global autologous cell therapy market for 2017-2021. To calculate the market size, the report considers the sales of autologous stem cell as well non-stem cell products.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA

According to the report, one of the major drivers for this market is increasing demand for effective drugs for cardiac and degenerative disorders. There has been an increased demand for providing effective drugs for cardiac and degenerative disorders globally. Prior to the advent of autologous cell therapies, there was no effective drug to repair a damaged heart. The discovery of possible cardiac autologous cells opened new possibilities for repairing damaged cardiac tissue caused by acute myocardial infarction or coronary artery disease.

Further, the report states that one of the major factors hindering the growth of this market is critical ethical challenges with respect to stem cell research. Over the years, there has been a continuous debate over ethical issues related to stem cell therapy. Embryonic stem cell development is continuously debated upon by scientists and policy makers. The use of human embryonic stem cells in research has always concerned decision makers and the scientific fraternity. Some of the issues include the cloning of embryonic stem cells and the destruction of embryos to create cell lines.

Global Autologous Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global autologous cell therapy market: Brainstorm Cell Therapeutics, Holostem Advanced Therapies, Osiris Therapeutics, Valeant, and Vericel.

Other Prominent Vendors in the market are: AbbVie, American CryoStem, AM-Pharma, Anterogen, apceth Biopharma, Astellas Pharma, Athersys, Baxter International, Beike Biotechnology, BIOTIME, bluebird bio, Bristol-Myers Squibb, Brainxell, Caladrius Biosciences, Cellular Biomedicine, Cellular Dynamics International, Cesca Therapeutics, CHA Biotech, Chugai Pharmaceutical, Citospin, Corestem, Cytori Therapeutics, Daiichi Sankyo, Fujifilm, Gamida Cell, Global Stem Cells, Grupo Ferrer Internacional, GlaxoSmithKline, Hemostemix, Histocell, International Stem Cell, Ivy Institute of Stem Cells, Japan Regenerative Medicine, Kangstem Biotech, Kiadis Pharma, Laboratorios Salvat, MEDIPOST, Mesoblast, Nuo Therapeutics, Opsis Therapeutics, Pharmicell, Pluristem Therapeutics, Promethera Biosciences, Q Therapeutics, ReNeuron, RHEACELL, Salus Medical Solutions, Sangamo Therapeutics, Shire, Steminent Biotherapeutics, Sumitomo Dainippon Pharma, Taiwan Bio Therapeutics, Takeda Pharmaceutical, Teva Pharmaceutical Industries, Thoratec, TiGenix, Translational Biosciences, TWO CELLS, U.S. Stem Cell, ViaCyte, and VistaGen Therapeutics.

Market driver
  • Increasing demand for effective drugs for cardiac and degenerative disorders
  • For a full, detailed list, view our report

Market challenge
  • Critical ethical challenges with respect to stem cell research
  • For a full, detailed list, view our report

Market trend
  • Private funding will fuel market growth
  • For a full, detailed list, view our report

Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Spanning over 92 pages Global Autologous Cell Therapy Market 2017 - 2021” report covers Executive summary, Scope of the report, Research Methodology, Introduction, Market landscape, Pipeline Landscape, Market segmentation by application, Market Segmentation by therapy, Geographical segmentation, Decision framework, Drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

Please visit this link for more details: http://mrr.cm/UmW

Related Reports;

Global Lupus Therapeutic Market 2017-2021 - Visit at - http://mrr.cm/Umm

Global Patient Warming Devices Market 2017-2021 - Visit at - http://mrr.cm/Ums

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

Global Blood Clot Retrieval Devices Market to grow at a CAGR of 6.58% during the period 2017 - 2021; Finds New Report

Global Blood Clot Retrieval Devices Market 2017 - 2021

Report forecast the global blood clot retrieval devices market to grow at a CAGR of 6.58% during the period 2017-2021.

The blood clot retrieval devices are used for endovascular revascularization, which is caused due to stroke. The clot retrieval process is performed within eight hours of the onset of stroke symptoms; the whole process of blood clot retrieval takes about two hours. Due to technological advances, the combination of intra-arterial thrombolysis and ultrasound are used to disrupt the clot and treat the individual with any ischemic stroke.

The report covers the present scenario and the growth prospects of the global blood clot retrieval devices market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales, volume, and value of blood clot retrieval devices.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA

According to the report, one of the major drivers for this market is increasing market entrants by launching new products. The medical device market is one of the rapidly growing markets across the globe. The market is fragmented due to the presence of numerous manufacturers providing blood clot retrieval devices. Hence, the inflow of new product launches in the market is the constant phenomenon. The new technologies and upgradation of devices are the two factors which drive the market. The interventional market has been one of the lucrative markets from the technological perspective. The peripheral vascular market is considered as one of the fastest growing markets with the increase in the incidence of cardiovascular diseases. The devices are being improvised by the existing market players to hold a stand in the competitive market.

Further, the report states that one of the major factors hindering the growth of this market is unfavorable results of futile recanalization procedures. Due to a rise in the vascular diseases globally, the adoption of the blood clot retrieval devices has also increased, but the unfavorable outcomes of the procedures are considered as one of the constraints for the growth of the market. Moreover, most patients are ignorant about the causes and symptoms of the diseases. Failure to diagnose the disease during its initial stages prevents patients from opting for peripheral vascular treatments.

Global Blood Clot Retrieval Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

key players in the global blood clot retrieval devices market: Argon Medical Devices, Boston Scientific, and Medtronic.

Other Prominent Vendors in the market are: Abbott, Acandis, AngioDynamics, B. Braun, Biosensors International, Biotronik, CONMED, Cordis, EKOS, ENDOCOR, ENDO-FLEX, JOTEC, Meril Life Sciences, Neuravi, NexGen Medical Systems, OrbusNeich, perflow, Rontis, STENTYS, Stryker, and Teleflex.

Market driver
  • Increasing market entrants by launching new products
  • For a full, detailed list, view our report

Market challenge
  • Unfavorable results of futile recanalization procedures
  • For a full, detailed list, view our report

Market trend
  • Strategic acquisition of business segments
  • For a full, detailed list, view our report

Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Spanning over 70 pages Global Blood Clot Retrieval Devices Market 2017 - 2021” report covers Executive summary, Scope of the report, Research Methodology, Introduction, Market landscape, Market segmentation by product, Market segmentation by end-user, Geographical segmentation, Decision framework, Drivers and challenges, Market trends, Vendor landscape, Key vendor analysis, Appendix.

Please visit this link for more details: http://mrr.cm/Ume

Related Reports;

Global Mechanical Thrombectomy Devices Market 2017-2021 - Visit at - http://mrr.cm/Umn

Global Pen Needles Market 2017-2021 - Visit at - http://mrr.cm/Umh

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

Global Biochips Market is expected to reach $17,851.1 million by 2023; Finds New Report

Biochips (Microarrays/Microfluidics) Global Market - Forecast To 2023

Biochips come handy as thousands of experiments are performed on a small chip with a solid platform and acts like a mini laboratory. Usage of biochips has increased in the past decade as its application varies from high throughput screening in drug discovery to personalized medicine.

The global biochips market is expected to grow at double digit CAGR to reach $17,851.1 million by 2023. Biochips market is mainly classified into technologies, products, application and end-users. The global biochips market is broadly classified as micro arrays and microfluidics based on technology. Based on products, the market is classified into Instruments, Reagents & Consumables and Software & Services.

Biochips market is segmented on the basis of application as Genomics, Proteomics, Drug discovery, Diagnostics, Food & agricultural testing and others. Genomics application segment is further classified into SNP Genotyping, Gene Expression and Others where as Drug discovery segment is further sub segmented into Target Identification & Validation, HTS (High Throughput screening) and Lead Optimization.

Diagnostics segment is further divided into Cancer diagnostics and other diagnostics. End-Users are further classified into Pharmaceutical & Biotech companies, Academic & Research laboratories, Diagnostic laboratories, CROs (Contract and Research Organizations) and others.

Revolution in the field of genomics, proteomics as well as rapid drug discovery increased the demand for biochips. In addition, increase in diagnosis and treatment of cancer and genetic diseases, approval for personalized medicines and invention of novel technologies in biochips drives the market of biochips. Standardization and quality assurance of biochips, technological ease in handling the biochips especially in the areas of diagnosis and treatment, high cost along with ethical and social issues hinders the market growth.

Lifestyle changes owing to increase in cancer, diabetes and hypertension patients, early diagnosis and treatment of diseases, advancement of biochips with its wide application areas shows that biochip market has vast opportunities in the coming years.

North America accounts for the highest market share in 2016 and followed by Europe. Steep rise in genetic diagnosis, huge corporate outsourcing for drug discovery, increase in personalized medicines and favourable government policies makes U.S. the leader of Biochips market. However, Asian countries especially China and Japan are the fastest growing regions with its growing demand for biochips and increasing research investments. Asia-Pacific grows with a highest CAGR of XX% from 2016 to 2023.

Major players in biochips market include Abbott laboratories (U.S.), Agilent Technologies (U.S.), Becton-Dickinson Company (U.S.), Bio-Rad Laboratories (U.S.), Danaher Corporation (U.S.), Fluidigm Corporation (U.S.), GE Healthcare (U.S.), Illumina (U.S.), PerkinElmer, Inc. (U.S.) and Thermo Fisher Scientific, Inc. (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions:
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World

Spanning over 404 pages Biochips (Microarrays/Microfluidics) Global Market - Forecast To 2023” report covers Executive Summary, Introduction, Market Analysis, Biochips Global Market, By Technology, Biochips Global Market, By Products, Biochips Global Market, By Applications, Biochips Global Market, By End-Users, Regional Market Analysis, Competitive Landscape, Major Companies. This Report Covered 123 Companies Few Are - Abbott Laboratories, Agilent Technologies, Becton Dickinson And Company, Biorad Laboratories, Danaher Corporation, Fluidigm Corporation, Ge Healthcare, Illumina, Inc., Perkinelmer, Inc., Thermofisher Scientific.

Please visit this link for more details: http://mrr.cm/Um2

Find all Pharma and Healthcare Technology Reports at: http://www.marketresearchreports.com/pharma-healthcare-technology

Tuesday 20 June 2017

Global Drugs For Herpes Labialis Industry 2017 Market Report; Launched via MarketResearchReports.com

Global Drugs For Herpes Labialis Industry Market Research 2017

In this report, we analyze the Drugs For Herpes Labialis industry from two aspects. One part is about its production and the other part is about its consumption. In terms of its production, we analyze the production, revenue, gross margin of its main manufacturers and the unit price that they offer in different regions from 2012 to 2017. In terms of its consumption, we analyze the consumption volume, consumption value, sale price, import and export in different regions from 2012 to 2017. We also make a prediction of its production and consumption in coming 2017-2022.

At the same time, we classify different Drugs For Herpes Labialis based on their definitions. Upstream raw materials, equipment and downstream consumers analysis is also carried out. What is more, the Drugs For Herpes Labialis industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.


The report can answer the following questions:
1. What is the global (North America, South America, Europe, Africa, Middle East, Asia, China, Japan) production, production value, consumption, consumption value, import and export of Drugs For Herpes Labialis?
2. Who are the global key manufacturers of Drugs For Herpes Labialis industry? How are their operating situation (capacity, production, price, cost, gross and revenue)?
3. What are the types and applications of Drugs For Herpes Labialis? What is the market share of each type and application?
4. What are the upstream raw materials and manufacturing equipment of Drugs For Herpes Labialis? What is the manufacturing process of Drugs For Herpes Labialis?
5. Economic impact on Drugs For Herpes Labialis industry and development trend of Drugs For Herpes Labialis industry.
6. What will the Drugs For Herpes Labialis market size and the growth rate be in 2022?
7. What are the key factors driving the global Drugs For Herpes Labialis industry?
8. What are the key market trends impacting the growth of the Drugs For Herpes Labialis market?
9. What are the Drugs For Herpes Labialis market challenges to market growth?
10. What are the Drugs For Herpes Labialis market opportunities and threats faced by the vendors in the global Drugs For Herpes Labialis market?

Objective of Studies:
1. To provide detailed analysis of the market structure along with forecast of the various segments and sub-segments of the global Drugs For Herpes Labialis market.
2. To provide insights about factors affecting the market growth. To analyze the Drugs For Herpes Labialis market based on various factors- price analysis, supply chain analysis, porte five force analysis etc.
3. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- North America, Europe, Asia, and Rest of the World.
4. To provide country level analysis of the market with respect to the current market size and future prospective.
5. To provide country level analysis of the market for segment by application, product type and sub-segments.
6. To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market.
7. To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Drugs For Herpes Labialis market.

Spanning over 149 pages Global Drugs For Herpes Labialis Industry Market Research 2017” report covers Industry Overview of Drugs For Herpes Labialis, Industry Chain Analysis of Drugs For Herpes Labialis, Manufacturing Technology of Drugs For Herpes Labialis, Major Manufacturers Analysis of Drugs For Herpes Labialis, Global Production, Revenue and Price Analysis of Drugs For Herpes Labialis by Regions, Manufacturers, Types and Applications, Global and Major Regions Capacity, Production, Revenue and Growth Rate of Drugs For Herpes Labialis 2012-2017, Consumption Volume, Consumption Value, Import, Export and Sale Price Analysis of Drugs For Herpes Labialis by Regions, Gross and Gross Margin Analysis of Drugs For Herpes Labialis, Marketing Trader or Distributor Analysis of Drugs For Herpes Labialis, Global and Chinese Economic Impact on Drugs For Herpes Labialis Industry, Development Trend Analysis of Drugs For Herpes Labialis, Contact information of Drugs For Herpes Labialis, New Project Investment Feasibility Analysis of Drugs For Herpes Labialis, Conclusion of the Global Drugs For Herpes Labialis Industry 2017 Market Research Report.

Please visit this link for more details: http://mrr.cm/UWz

For related reports please visit: DrugsMarket Research Reports

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

Monday 19 June 2017

The Top 150 Manufacturers Of Point-Of-Care Instruments and Tests; New Report Launched

The Top 150 Manufacturers Of Point-Of-Care Instruments & Tests

Did you know?

- As of March 31, 2016, Abaxis, Inc. had 549 full-time employees.
- Peter Koerte is President, Point of Care Diagnostics at Siemens Healthineers.
- Four HemoCue point-of-care tests are performed each second worldwide.
-iLine Microsystems earned the 2016 Frost & Sullivan Enabling Technology Leadership Award.
- With over 80,000 placements in high-acuity settings worldwide and 35 million test cartridges produced annually, Abbott Point Of Care’s i-STAT® System has a global impact on bedside point-of-care testing.
- QuantuMDx Group’s first available test will take the guess work out of warfarin dosage by identifying at the point-of-care, subsets of the population who could develop life-threatening bleeds on the standard dose.
- ChroMedX Corp’s HemoPalm Handheld Blood Analyzer System is the only handheld blood analysis technology which combines Blood Gases and Electrolytes with full CO-Oximetry.
- At 60 seconds for a reading, bioLytical Laboratories’ INSTI® Kit is the fastest HIV diagnostic assay in the world today.
- Arbor Vita Corporation’s flagship point-of-care product - the OncoE6™ Cervical Test - has proven to be the most accurate test available worldwide for detecting cervical cancer.
- On March 7, 2017, Alere Inc. announced that its Alere™ i RSV test, the first molecular test that can be used at the point-of-care to detect RSV (respiratory syncytial virus) infection in children and adults in 13 minutes or less,had been granted CLIA waiver by the FDA.
- As well as developing its own family of products, Philips Handheld Diagnostics is open to collaborating with other healthcare companies to exploit the full potential of its Minicare technology.
- For the fiscal year ended March 31, 2016, Abaxis, Inc. reported revenues from continuing operations of $218.9 million.
- On January 20, 2017 Werfen and its subsidiary Instrumentation Laboratory (IL) announced the acquisition of Accriva Diagnostics.

These are just a tiny sample of the 1,000's of facts to be found in ‘The Top 150 Manufacturers Of Point-Of-Care Instruments & Tests’.

This unique and comprehensive report identifies and profiles the 150 leading companieswith a focus on point-of-care diagnostics. There is no other report on the market that does this.

The companies profiled in this report are located across the globe from the United States and Europe to India and China. They are the ones with the experience, know-how and resources that enable them to develop, manufacture and market innovative products that can compete effectively in global markets. They range from large companies such as Nova Biomedical Corporation to smaller niche companies such as BioDirection, Inc..

Profile information for each company in ‘The Top 150 Manufacturers Of Point-Of-Care Instruments & Tests’ typically includes:

- Company Contact Information - Address, Telephone and Fax Numbers, Email and Website Addresses
- Key Company Decision Makers - From CEO and Main Board, to Key Senior Managers
- Specialised fields such as Company Description, POC Specialties, Ownership, Number of Employees and Revenue

Report Target Market:

1) Point-Of-Care Manufacturing Companies

Usage: competitive/financial analysis and strategic partner/alliance identification.

2) Suppliers

‘The Top 150 Manufacturers Of Point-Of-Care Instruments & Tests’ is perfect for suppliers of raw materials, technology and services to identify top potential customers.

3) Distributors

This report is ideal for distributors of point-of-care instruments and tests to identify the leading manufacturers with the best products.

4) Industry Associations:

‘The Top 150 Manufacturers Of Point-Of-Care Instruments & Tests’ is a useful reference tool for in-vitro diagnosticsindustry associations.

Note: Most people will be aware of some of the major manufacturers of point-of-care instruments and tests such as EKF Diagnostics, PTS Diagnostics and SD Biosensor, Inc. but this major new report looks at all 150 of the top companies - companies like:

- Biosensia Ltd. - Founded in 2009 and headquartered in Dublin, Ireland, Biosensiais a science focused, venture backed business established specifically to develop and exploit its novel and proprietary technology, RapiPlex.RapiPlex is a point-of-care diagnosis system based on a set of proprietary technologies capable of producing quantitative and qualitative laboratory quality test results.Itcomprises a disposable assay cartridge and a small table top instrument, making it possible to transition complex immunoassays from the centralised reference laboratory to a doctor’s office or patient’s bedside, facilitating near patient care without compromising analytical performance.The Company’s aim is to make RapiPlex a method of choice for testing multiple analytes in a matter of minutes. Biosensiais interested in exploring product commercialisation under license agreement. It has already signed two development agreements with external partners for products for TB triage and for the monitoring of systemic Lupus and discussions are ongoing in severalother areas including sepsis and infectious disease panels. The Company is led by Niamh O’Luanaigh, Chief Operating Officer.

- Sarissa Biomedical Limited - Sarissa Biomedical’s patented technology delivers a step change in enzymatic biosensor sensitivity and selectivity to detect and measure biomarkers in finger-prick blood samples within minutes, using low cost, single use biosensors and handheld readers. This new generation of biosensors is set to transform emergency clinical care, creating point-of-care diagnostic solutions not previously possible. The Company’s first application is stroke and it expects to make a CE marked product available during 2017. Sarissa Biomedical is working on other diagnostic applications in several major disease areas such as TBI, heart attacks and sepsis. The Company was founded in 2002 and is headquartered in Coventry, United Kingdom. Dr Everard Mascarenhas is Sarissa Biomedical’s Chief Executive Officer.

- Zenosense, Inc.-Zenosense’s primary focus, through their joint venture ownership in MIDS Medical Ltd., is the development of a cost-effective, hand-held, point-of-care, rapid cardiac diagnostic device, MIDS Cardiac™.MIDS Cardiac™ enables the rapid detection of very low levels of cardiac markers with a primary focus on troponin I and T. The device is designed to equal or exceed gold standard laboratory levels of accuracy, at the point-of-care. It is intended to be used with a minimum of training by any ER nurse or by paramedics at the scene. The Companybelieves that MIDS Cardiac™ will revolutionise the diagnosis and management of suspected Acute Myocardial Infarction (AMI), that it will be in universal demand and that it will rapidly penetrate a multi-billion dollar market.Zenosense was founded in 2008, is headquartered in Valencia, Spain and is led by Carlos Gil, Chief Executive Officer.

Report data field structure is as follows:
- Company Name
- Address
- Telephone
- Fax
- Email
- Website
- Year Established
- Number of Employees
- Key Executives
- Company Description
- Products
- POC Specialties
- Revenue ($U.S. million)
- Location Status
- Ownership
- Stock Exchange/Ticker Symbol
- Parent Company Name

Publisher is one of the world’s leading companies in life sciences publishing. It has a large portfolio of best-selling reports spanning diagnostics, pharmaceuticals, biotechnology and medical devices. It’s customers include most of the world’s major companies in these sectors e.g. Abbott Laboratories, ACON Laboratories, Alcon, Alere, Allergan, Aurobindo Pharma, Axis-Shield, Baxter, Bayer, B. Braun, BD, Biomerieux, Biomet, Boditech Med, Boehringer Ingelheim, CareFusion, Covance, Covidien, C.R. Bard, Edwards Lifesciences, EKF Diagnostics, Fresenius, GE Healthcare, Genzyme, HemoCue, Intuitive Surgical, Ipsen, Johnson & Johnson, Medtronic, Merit Medical Systems, Millipore, Mölnlycke Health Care, Novartis, Paul Hartmann, Philips Medical, Qiagen,Quidel, Siemens Healthcare, Smith & Nephew, Synthes, Teleflex, Teva, Tosoh, Zentiva etc.. Publisher also counts many multinational financial services, law and management consulting firms such as Bain & Company, McKinsey & Company and The Boston Consulting Group among its customers.

Publisher currently has customers in some forty countries across the globe e.g. Austria, Australia, Belgium, Brazil, Canada, Cyprus, Czech Republic, Denmark, France, Germany, Finland, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Kuwait, Luxembourg, Malta, Mauritius, Netherlands, Pakistan, Peru, Portugal, Russia, Saudi Arabia, Serbia, Singapore, Slovenia, South Africa, Spain, Sweden, Switzerland, United Kingdom, and the United States.

Publisher' reports help you make informed decisions about the markets and organisations that affect your business.

- Learn more about your target markets and target companies
- Top level research on all the major players in a market
- See which organisations dominate your major markets
- Get detailed information on particular organisations

Please visit this link for more details: http://mrr.cm/UWP

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare